Literature DB >> 11493100

Complete remission of scleromyxedema following autologous stem cell transplantation.

A M Feasel1, M L Donato, M Duvic.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11493100

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN： 0003-987X


× No keyword cloud information.
  5 in total

1.  [Scleromyxedema. A chronic progressive systemic disease].

Authors:  A Kreuter; M Stücker; A G A Kolios; P Altmeyer; K Möllenhoff
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

Review 2.  [Scleromyxedema].

Authors:  M Neufeld; C Sunderkötter; R K C Moritz
Journal:  Hautarzt       Date:  2018-11       Impact factor: 0.751

3.  Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.

Authors:  Michele L Donato; Adrienne M Feasel; Donna M Weber; Victor G Prieto; Sergio A Giralt; Richard E Champlin; Madeleine Duvic
Journal:  Blood       Date:  2005-09-22       Impact factor: 22.113

4.  Scleromyxedema: a case report and review of the literature.

Authors:  Mohamed Allam; Mohamed Ghozzi
Journal:  Case Rep Dermatol       Date:  2013-06-11

5.  Atypical scleromyxedema presenting with cutaneous and cardiovascular manifestations.

Authors:  Sue-Ann Teh; David A Kandiah
Journal:  Int Med Case Rep J       Date:  2016-09-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.